The oral administration of large amounts of sitosterol to patients with coronary atherosclerosis has resulted in statistically significant decrease in serum cholesterol in one half of the trial periods. 
However, because of the fluctuation of the serum cholesterol that occurs in patients with coronary atherosclerosis, further study will be necessary to demonstrate that the decrease in serum cholesterol coincident with sitosterol administration is not due to the lability of the serum lipids in this group of individuals.
THERE are conflicting reports in the literature concerning the effect of plant sterols on serum lipid concentrations. Pollack' in 1953 reported that 5 to 10 Gm. of a sitosterol mixture (prepared from soybeans) given orally daily for 7 to 28 days caused a fall in serum cholesterol in 24 of 26 patients. Best et al. 2' in 1954 and 1955 found that the feeding of 20 to as much as 50 Gm. of sitosterol daily to 14 ambulatory patients during study periods of 13 to (4 weeks resulted in a mean fall in serum cholesterol values of 16 per cent in 12 "hypercholesterolemic" subjects and of 6.8 per cent in 2 "niormocholesterolemic" subjects. The falls in serum cholesterol were accompanied by decreases in total serum lipid and serum neutral fat. Joyner and Kuo4 reported significant decreases in serum cholesterol within a week or more upon the oral administration of 12 to 24 Gm. of 0-sitosterol suspension to both "normocholesterolemic" and "hypercholesterolemic" patients. They found no significant effect when the dosage alas less than 10 Gm. a day. Farciuhar 18 Gm. of f-sitosterol for periods of 12 to 24 weeks. In a recent article, Barber and Grant' reported a suggestive fall in serum cholesterol in 24 of 26 subjects receiving 9 Gm. of f-sitosterol daily. In these 24 patients there was a reduction in the minimal serum cholesterol level under the sitosterol regimen, but in only 17 was the mean level lowered. However, in a footnote to the article, without presentation of data, these workers stated that a significant decrease in serum cholesterol occurred when the daily amount of sitosterol was increased from 9 to 18 Gm. Wilkinson and his co-workers,7 8 however, reported that the oral administration of 15 to 30 Gm. of -y-sitosterol daily for 3 to 35 weeks failed to alter the serum cholesterol in 7 patients.
The present report summarizes a 16-month study on the changes in serum lipid concentrations during the oral administration of sitosterol to 13 patients with coronary atherosclerosis.
METHOD Seven hospitalized and 6 ambulatory patients composed the clinical group. Among the hospitalized patients, 4 of the 7 had historical and electrocardiographic evidence of coronary atheroselerosis and mvocardial infarction; 1 (HB) had primary myxeclema with clinical and electrocardiographic evidence of coronary atherosclerosis; and the remaining 2 (JAK and EL) had angina pectoris and hemiplegia believed to be due to cerebral thrombosis.
In the ambulatory group, 3 of the 6 patients had coronary insufficiency apparently related to coronary atherosclerosis. The remaining 3 There were 9 periods of placebo administration in the hospitalized patients. The serum cholesterol returned toward values not significantly different from the initial control in (6 instances; however, in 3 patients the average serum total cholesterol in the final placebo or control period was significantly higher than the initial control (JAK, AS, EL).
In table 2 the mean serum total cholesterol for the entire sitosterol feeding period has been paired with the initial control value for each of the 10 subjects. It caii be seen that in only 5 of the 10 patients was there a statistically significant depression of the mean serum total cholesterol during sitosterol administration as compared to the initial control values. Figure  1 shows the effect of 0-sitosterol and the placebo on the serum lipid pattern of patient SS. The mean fall in serum total cholesterol for all 10 subjects was 6.6 per cent (17 mg. per cent) with a range of 0 to 14 per cent (+12 to -33 mg. per cent). The mean fall in serum total cholesterol for the 5 subjects in whom the depression was statistically significant was 9 per cent (23.4 mg. per cent) with a range of 7 to 14 per cent (17 to 33 mg. per cent). tion. In no instance was there evidence of clinical benefit from sitosterol administration as judged by incidence of chest pain or improvement in the electrocardiogram.
All 3 patients with coronary atherosclerosis and associated xanthomatosis exhibited falls in serum total cholesterol during the sitosterol feeding period (table 5) . However, in each instance, after 6 to 9 weeks on sitosterol, the serum cholesterol rebounded towards control levels ( fig. 2) . This was reflected in the mean change in that the mean serum total cholesterol during sitosterol administration was statistically significantly lower than the initial control value in only 2 of the 3 patients (CK and WF). The mean fall in serum total cholesterol for the group during sitosterol administration was 12 per cent (66.5 mg. per cent) with a range of 6 to 22 per cent (32 to 81 mg. per cent).
In this group the total lipid did not change significantly during sitosterol administration; and in 2 of the 3 (CK and WF) the neutral fat tended to rise during sitosterol administration. 
